TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Sequence variations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs in wild-type and Trem2-/- microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that loss of TREM2 impairs appropriate microglial responses to injury and signals that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic brain slice assay, absence of TREM2 reduces the distance migrated by microglia. Moreover, migration towards defined chemo-attractants is reduced upon ablation of TREM2 and can be rescued by TREM2 re-expression. In vivo, microglia lacking TREM2 migrate less towards injected apoptotic neurons, and outgrowth of microglial processes towards sites of laser-induced focal CNS damage in the somatosensory cortex is slowed. The apparent lack of chemotactic stimulation upon depletion of TREM2 is consistent with a stable expression profile of genes characterizing the homoeostatic signature of microglia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Trem2-mediated signaling is known to inhibit the transition of microglia to a more Disease-Associated Microglia (DAM) state characterized by enhanced migration, chemotaxis, and phagocytosis [44,45].”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, lack of Trem2 reduces chemotaxis and phagocytosis of microglia (54, 55).”
From Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis (2021) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglia with TREM2 loss-of-function cannot transition to the DAM state and are locked in a homeostatic state, in which they no longer respond normally to pathological challenges [34].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“compelling evidence suggesting that TREM2 can regulate microglia phagocytic activity [44,45]”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“TREM2 is a cell-surface receptor of the immunoglobulin superfamily implicated in a variety of microglial functions, such as phagocytosis, chemotaxis and survival21–23.”
From PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages (2021) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 2×
“The migration distance was measured using Fiji [65] by drawing a line between the migrated cell and the slice culture border.”
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 1×
“However, the most commonly shared pathological principle of basically all neurodegenerative diseases and many other neurological disorders is gliosis associated with an inflammatory response [4].”
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“In the WT-and Trem2-deficient offspring, we induced a focal CNS damage in the somatosensory cortex using a focussed laser beam [45 – 47] and acquired time-lapse images of the microglial response using in vivo two-photon microscopy (Fig 5A).”
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Furthermore, for several neurodegenerative diseases, evidence exists that soluble oligomers, which may be rather stable intermediates of the aggregation process of amyloidogenic proteins, are the executers of neurotoxicity [2].”
Self-citationSynaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 1×
“Microglia are the resident macrophages of the central nervous system and play a pivotal role in synaptic pruning and apoptotic cell clearance during development of the nervous system [51 – 56].”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 1×
“As the innate immune cells of the brain, microglia are the first cells to respond to neuronal damage [16,41].”
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Cited by
Items 201–300 of 355
Joshi, P., Riffel, F., Kumar, S., Villacampa, N., Theil, S., Parhizkar, S., Haass, C., Colonna, M., Heneka, M. T., Arzberger, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01263-x · Cited by 18
Self-citationThe Role of TREML2 in Alzheimer’s Disease
Wang, S., Gong, P., Yan, E., Zhang, Y., & Jiang, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200406 · Cited by 19
Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging
Liu, T., Li, J., Wu, H., Qiao, J., & Wei, J. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101719 · Cited by 23
“117 Age-dependent TREM2 attenuation is particularly pronounced in PD animal models, where aged mice display markedly reduced phagocytic efficiency toward α -synuclein aggregates compared to their younger counterparts.”
Microglia and neuroinflammation: function, heterogeneity, and crosstalk
Zong, S., Cui, X., Wu, S., & Lu, Z. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01438-3 · Cited by 30
“For instance, microglia isolated from adult TREM2-de fi cient mice have been shown to maintain a canonical homeostatic state, given that they are less effective as stimuli such as amyloids and fail to develop the typical transcriptional DAM pro fi le in AD [53, 54].”
Bianchin, M. M., & Snow, Z. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.032 · Cited by 18
Microglial Reactivity Correlates with Presynaptic Loss Independent of β‐Amyloid and Tau
Lan, G., Chen, X., Yang, J., Sun, P., Cai, Y. Q., Li, A., Zhu, Y., Liu, Z., Ma, S., Guo, T., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26885 · Cited by 20
“7,15,32 Supporting this, we further noticed an association between faster increases in CSF sTREM2 and decreases in CSF PGRN.”
Sepulveda, J., Kim, J. Y., Binder, J., Vicini, S., & Rebeck, G. W. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00714-y · Cited by 22
“In addition, TREM2 is involved in microglia migration, phagocytosis, and expression of chemotactic receptors [7, 81, 82].”
BackgroundSHIP inhibition mediates select TREM2-induced microglial functions
Ramakrishnan, G. S., Berry, W. L., Pacherille, A., Kerr, W. G., Chisholm, J. D., Pedicone, C., & Humphrey, M. B. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.04.002 · Cited by 17
de Weerd, L., Hummel, S., Müller, S. A., Paris, I., Sandmann, T., Eichholtz, M., Gröger, R., Englert, A. L., Wagner, S., Ha, C., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00878-1 · Cited by 20
Self-citationVEGF controls microglial phagocytic response to amyloid-β
Gea, P. D., Benkeder, S., Bouvet, P., Aimard, M., Chounlamountri, N., Honnorat, J., Do, L.-D., & Meissirel, C. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1264402 · Cited by 19
The role of microglial TREM2 in development: A path toward neurodegeneration?
Matteoli, M. (2024) · Glia · doi:10.1002/glia.24574 · Cited by 17
“…et al., 2017), regulates their phagocytic activity (Kim et al., 2017; Takahashi et al., 2005), modulates microglia motility (Jairaman et al., 2022; Mazaheri et al., 2017) and controls microglia metabolism, including biosynthetic pathways and ATP levels (Ulland et al., 2017), cholesterol…”
MEK1/2 activity modulates TREM2 cell surface recruitment
Schapansky, J., Grinberg, Y. Y., Osiecki, D. M., Freeman, E. A., Walker, S. G., Karran, E. H., Gopalakrishnan, S. M., & Talanian, R. V. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014352 · Cited by 15
Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury
Zhang, C., & Chen, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03094-w · Cited by 14
Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
Robbins, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373670 · Cited by 16
“Progranulin and Trem2 are commonly mentioned as antagonistic targets against the innate immune system in FTD or AD whereby decreased progranulin increases microglial activity, whereas decreased Trem2 causes impaired microglial activation (Mazaheri et al., 2017; Götzl et al., 2019; Table 3 ).”
The triggering receptor expressed on myeloid cells 2–apolipoprotein E signaling pathway in diseases
Lyu, S., Lan, Z., & Li, C. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002167 · Cited by 15
“Triggering receptor expressed on myeloid cells 2 (TREM2) plays an important role in the regulation of life activities of many cells, including survival,([1,2]) proliferation,([3,4]) differentiation, phagocytosis,([1,5-7]) and inflammatory response.”
BackgroundMicroglial Mayhem NLRP3 Inflammasome's Role in Multiple Sclerosis Pathology
Fan, H., Fu, Q., Du, G., Ling, Q., Shi, X., Wang, D., & Yang, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70135 · Cited by 16
“Reactive MG involves the downregulation of numerous homeostatic genes, indicating impaired and lost key homeostatic functions during MS that may exacerbate neuro-degenerative processes in progressive MS pathology [78, 81–83].”
Decoding microglial functions in Alzheimer’s disease: insights from human models
Rao, C., Semrau, S., & Fossati, V. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.02.011 · Cited by 14
Shi, M., Gong, Y., Wu, M., Gu, H., Yu, J., Gao, F., Ren, Z., Qian, M., Dang, B., & Chen, G. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.02.022 · Cited by 14
Pumo, A., & Legeay, S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148817 · Cited by 14
Le, L., Eliseeva, S. I., Plunk, E. C., Kara-Pabani, K., Li, H., Yarovinsky, F., & Majewska, A. K. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115176 · Cited by 17
Don’t know what you got till it’s gone: microglial depletion and neurodegeneration
Graykowski, D. R., & Cudaback, E. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308078 · Cited by 14
“They also influence developmental synaptic refinement through activation of TREM 2, a cell-surface triggering receptor and important genetic risk factor for AD involved in microglial migration, proliferation, and viability (Mazaheri et al., 2017).”
Frieß, L., Cheray, M., Keane, L., Grabert, K., & Joseph, B. (2021) · Molecular Brain · doi:10.1186/s13041-021-00794-7 · Cited by 13
Microglia at the Centre of Brain Research: Accomplishments and Challenges for the Future
Soares, N. L., & Vieira, H. L. A. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03456-1 · Cited by 18
Genetic variability in response to Aβ deposition influences Alzheimer’s risk
Salih, D. A., Bayram, S., Guelfi, M. S., Reynolds, R., Shoai, M., Ryten, M., Brenton, J., Zhang, D., Matarin, M., Botia, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/437657 · Cited by 12
Li, X., Qiu, Y., Zhou, J. H., & Xie, Z. (2021) · Current Genomics · doi:10.2174/1389202923666211216163049 · Cited by 15
“TREM2 is a surface receptor of microglia, and microglia with impaired TREM2 mutation function cannot clear brain plaques and show morphological changes and apoptosis [87].”
BackgroundGlycolytic metabolism supports microglia training during age-related neurodegeneration
Camacho‐Morales, A. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00363-2 · Cited by 11
“In addition, TREM2 ablation in microglia decreases chemotaxis and chemoattraction [73] and blocks the response to inflammatory stimuli and around amyloid plaques [27, 74], due in part to Sall1 and TGFbr1 genomic upregulation [75].”
BackgroundPromising molecular targets for pharmacological therapy of neurodegenerative pathologies
Неганова, М. Е., Aleksandrova, Y. R., Nebogatikov, V. O., Klochkov, S. G., & Ustyugov, A. A. (2020) · Acta Naturae · doi:10.32607/actanaturae.10925 · Cited by 11
Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression
Domowicz, M. S., Chan, W., Vázquez, P. N. C., Gonzalez, T., & Schwartz, N. B. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02302-z · Cited by 12
Ye, Q., Gao, W., Feng, J., Li, X., Li, J., Yang, F., Li, L., Zi, M., Wu, X., Gao, H., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71185 · Cited by 11
“90,91 This directly amplifies the synaptic toxic environment in this region, leading to abnormal synaptic pruning and accelerating the loss of connections.”
Potential Alzheimer’s disease drug targets identified through microglial biology research
Lepiarz‐Raba, I., Hidayat, T., Hannan, A. J., & Jawaid, A. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2335210 · Cited by 10
“Moreover, TREM2 is essential for several constitutive microglial functions, such as chemotaxis and phagocytosis [112,113].”
BackgroundVecchiarelli, H. A., Lopes, L. T., Paolicelli, R. C., Stevens, B., Wake, H., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_11 · Cited by 10
Lin, D., Kaye, S. D., Chen, M., Lyanna, A., Ye, L., Hammond, L. A., & Gao, J. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107874 · Cited by 16
Neuroinflammation als Motor der Alzheimer-Erkrankung
Castro‐Gomez, S., Binder, J., & Heneka, M. T. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0778-3 · Cited by 17
Headmasters: Microglial regulation of learning and memory in health and disease
Weinhard, L., d’Errico, P., & Tay, T. L. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.1.63 · Cited by 12
“In addition, it was demonstrated that loss of TREM2 led to reduced microglial chemotaxis and delayed responses to neuronal damage [182].”
Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microgliaPreprint
Colombo, A. V., Dinkel, L., Müller, S. A., Monasor, L. S., Schifferer, M., Cantuti‐Castelvetri, L., König, J., Vidatic, L., Brémovà-Ertl, T., Hecimovic, S. K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/789511 · Cited by 10
A qualitative analysis of an A β -monomer model with inflammation processes for Alzheimer’s disease
Ciuperca, I. S., Pujo-Menjouet, L., Tine, L. M., Torres, N., & Volpert, V. A. (2024) · Royal Society Open Science · doi:10.1098/rsos.231536 · Cited by 15
Borim, P. A., Mimura, L. A. N., Zorzella-Pezavento, S. F. G., Polonio, C. M., Peron, J. P. S., Sartori, A., & Fraga‐Silva, T. F. D. C. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2021.0206 · Cited by 9
Moretti, M., Caraffi, R., Lorenzini, L., Ottonelli, I., Sannia, M., Alastra, G., Baldassarro, V. A., Giuliani, A., Duskey, J. T., Cescatti, M., et al. (2023) · Cells · doi:10.3390/cells12091331 · Cited by 11
“receptor that acts as a regulator in the inflammatory response and phagocytosis, and its upregulation characterizes microglia that protect neurons from damage [75].”
BackgroundSchwarz, H., Bässler, S., Balta, D., Socher, E., Zunke, F., & Arnold, P. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113977 · Cited by 8
Que, X., Zhang, T., Liu, X. Y., Yin, Y., Xia, X., Gong, P., Song, W., Qin, Q., Xu, Q., & Tang, Y. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102732 · Cited by 8
“In the CNS, TREM2 has been implicated in various aspects of microglial activity, including proliferation, activation, phagocytosis, survival, and lipid metabolism (Deczkowska et al., 2020; Mazaheri et al., 2017; Li et al., 2022; Poliani et al., 2015; Ulland et al., 2017).”
InfluentialHe, J., Zhou, W., & Li, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02261-5 · Cited by 8
Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer’s Disease
Ghosh, S., Bhaskar, R., Singh, K. K., Sharma, S., Yarlagadda, B., Sinha, J. K., & Han, S. S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01651-0 · Cited by 11
“…or loss of TREM2 impair acti - vated microglial function, diminishing clearance functions and metabolic fitness, thereby increasing amyloid seed - ing and exacerbating neuritic pathology in vivo (Jay et al. 2015; Wang et al. 2015; Mazaheri et al. 2017; Ulland et al. 2017; Parhizkar et al. 2019).”
Trem2 Enhances Demyelination in the Csf1r+/− Mouse Model of Leukoencephalopathy
Biundo, F., Chiţu, V., Gökhan, Ş., Chen, E., Oppong‐Asare, J., & Stanley, E. R. (2023) · Biomedicines · doi:10.3390/biomedicines11082094 · Cited by 9
Peng, Y., Yang, G., Wang, S., Lin, W., Zhu, L., Dong, W., Shen, B., Nie, Q., Hong, S., & Li, L. (2023) · International Journal of Toxicology · doi:10.1177/10915818231216397 · Cited by 9
Zatcepin, A., Gnörich, J. S., Rauchmann, B., Bartos, L. M., Wagner, S., Franzmeier, N., Malpetti, M., Xiang, X., Shi, Y., Parhizkar, S., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00752-6 · Cited by 12
“We find some evidence for this hypothesis since microglia synchronicity decreased in mice with Trem2 loss of function that locks microglia in a homeostatic state [52].”
BackgroundSelf-citationCumplido‐Mayoral, I., Sánchez‐Benavides, G., Vilor‐Tejedor, N., López‐Martos, D., Brugulat‐Serrat, A., Milà‐Alomà, M., Falcón, C., Cacciaglia, R., Minguillón, C., Fauria, K., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02961-x · Cited by 13
Muñoz-García, M. I., Deming, Y. K., Lugo-Hernández, F., Johnson, S. C., Asthana, S., Kollmorgen, G., Quijano‐Rubio, C., Carlsson, C. M., Okonkwo, O. C., Pérez-Martínez, D. A., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00901-5 · Cited by 15
“Loss-of-function genetic variants affecting the microglial protein triggering receptor expressed on myeloid cells 2 (TREM2) increase AD risk by preventing microglia from transitioning to a protective disease-associated state [13].”
Carrillo, G. L., Su, J., Cawley, M. L., Wei, D., Gill, S. K., Blader, I. J., & Fox, M. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15770 · Cited by 17
“Under pathological conditions, activated microglia will migrate toward the site of injury by detecting different classes of membrane-bound and secreted chemoattractants (Fan et al., 2017 ; Hu et al., 2014; Mazaheri et al., 2017 ).”
The Role of TREM2 After Stroke: From Mechanisms to Therapeutic Potential
Zhou, T., Chen, A., Sun, Y., Huang, B., Xu, Y., & He, Q. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05622-w · Cited by 7
Synergistic potential of TREM2 agonists and exercise training in Alzheimer’s disease
Zhang, J., Schneider, B. A., Muguerza, E., Chung, E. K., & Hsu, C. G. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00124.2025 · Cited by 6
Weathered, C., Bardehle, S., Yoon, C., Kumar, N. N., Leyns, C. E. G., Kennedy, M. E., Bloomingdale, P., & Pienaar, E. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13095 · Cited by 11
“Specific microglial deficiencies in chemotaxis and phagocytosis have also been linked with AD progression, 37 further supporting our results.”
ResultPrimate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonism
Schauer, S. P., Cho, C. H., Novikova, G., Roth, G. A., Lee, J., Sharma, A. D., Foley, A. R., Ng, C., Shen, P., Choi, M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13921 · Cited by 5
Implication of microRNAs in Alzheimer's disease pathogenesis
Zoltowska, K. M., Laskowska-Kaszub, K., Nagaraj, S., & Wojda, U. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00009-8 · Cited by 8
GPR34 regulates microglia state and loss-of-function rescues TREM2 metabolic dysfunctionPreprint
Raju, K., Joy, D. A., Guldberg, S. M., Germain, K., Gould, N. S., Ha, C., Tatarakis, D., Dugas, J. C., Davis, S. S., Reeves, A. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646038 · Cited by 7
Feng, X., & Wang, H. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00484 · Cited by 5
Hat die Alzheimer-Forschung versagt? Das Scheitern amyloidbasierter klinischer Studien
Haass, C., & Levin, J. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0751-1 · Cited by 5
Self-citationProgranulin and neuropathological features of Alzheimer’s disease: longitudinal study
Nabizadeh, F., Zafari, R., & Initiative, A. D. N. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02715-9 · Cited by 6
“In contrast, the deficiency in progranulin increases the activity of microglia [34].”
BackgroundAkinluyi, E. T., Takahashi, K., Connolly, M. G., Poon, W. W., & Macauley, M. S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00805 · Cited by 5
Hou, K., An, Z., Xu, Y., Wang, J., Zhou, M., Liu, Y., Zhu, X., & Wei, J. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01247-x · Cited by 5
Tian, M., Wang, D., Zhang, C., Fan, J., Li, W., Liu, X., & Shi, J. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00173 · Cited by 6
Mitochondrial dysfunction in neurodegenerative disorders: mechanisms and therapeutic advances
Tong, Y., He, J. N., Zhou, L., Zhang, J., Ho, B. M., Du, L., Yip, Y. W. Y., Bisnauthsing, H., Chan, P. P. M., Tham, C. C. Y., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00480-x · Cited by 6
“Emerging neuroinflammatory modulators (for example TREM2 agonists or cGAS-STING inhibitors) are actively being deployed to quell the secondary glial-driven toxicity triggered by mitochondrial DNA release [92, 96].”
Joseph, E., Kunze, L. H., Schaefer, R., Palumbo, G., Kugelmann, B., Wagner, S., Lammich, S., Feederle, R., Willem, M., Werner, R. A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00457 · Cited by 8
Neuroimmune Dysfunction in Alzheimer’s Disease and Other Forms of Dementia
Yamane, T., Yoshioka, T., & Shimo, Y. (2024) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c23-00464 · Cited by 5
Targeting TREM2 signaling shows limited impact on cerebrovascular calcification
Sridhar, S., Zhou, Y., Ibrahim, A., Bertazzo, S., Wyss, T., Swain, A., Maheshwari, U., Huang, S., Colonna, M., & Keller, A. (2024) · Life Science Alliance · doi:10.26508/lsa.202402796 · Cited by 4
“…pathways involved in preventing or removing calci fi cations remains unknown, TREM2 is known to regulate key microglial functions like phagocytosis (Takahashi et al, 2005; Kleinberger et al, 2014), in fl ammation (Jiang et al, 2014), and migration to sites of neuronal injury (Mazaheri et al, 2017).”
BackgroundNegro‐Demontel, M. L., Evans, F., Cawen, F. A., Fitzpatrick, Z., Mason, H. D., Alí‐Ruiz, D., López‐Vales, R., Lago, N., & Peluffo, H. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106105 · Cited by 7
Alamer, S. A., & Sherif, F. E. (2025) · Biology · doi:10.3390/biology14030284 · Cited by 3
“Cell chemotaxis has also been linked to the development of neurodegenerative diseases [43].”
Plantera, L., Immig, K., Fritsche, A., Reinicke, M., Zemer, A., Monsonego, A., Ceglarek, U., & Bechmann, I. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70168 · Cited by 3
“Lack of TREM2 lock microglia in a homeostatic state [113].”
Zhang, C., Wang, H., Hong, S.-H., Yan, R., & Shin, D. (2023) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm58861.2023.10386053 · Cited by 3
“Microglia’s role in apoptosis is also well established, specifically, TREM2-deficient microglia’s increased apoptosis [24].”
BackgroundGenetik der Alzheimer-Krankheit
Bajaj, T., Ramírez, A., & Wagner-Thelen, H. (2018) · Medizinische Genetik · doi:10.1007/s11825-018-0193-3 · Cited by 4
“Durch die Beteiligung von ABI3 an derRegulationdesAktinzytoskeletts [55] wäre es denkbar, dass sich eine Fehlfunktion von ABI3 auf TREM2-vermittelte, chemotaktische und phagozytotische Prozesse auswirken könnte [29, 42].”
BackgroundSayed, F. A., Kodama, L., Udeochu, J. C., Fan, L., Carling, G. K., Le, D., Li, Q., Zhou, L., Mathys, H., Wang, M., et al. (2020) · doi:10.1101/2020.07.24.218719 · Cited by 3
Distinct effects of disease-associated TREM2 R47H/+ and T66M mutations on iPSC-derived microgliaPreprint
Penney, J., Ralvenius, W. T., Loon, A. R., Cerit, O., Dileep, V., Milo, B., Woolf, H., & Tsai, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.05.511003 · Cited by 3
“In one common injury model, microglia extend processes and migrate toward sites of laser-induced damage, a process that is impaired in heterozygous and homozygous TREM2 knockout mice (Mazaheri et al., 2017; Sayed et al., 2018).”
BackgroundGlia in Neurodegenerative Disease
Crowley, G., Attwell, D., Phatnani, H. P., Sontheimer, H. W., & Hong, S. Y. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041375 · Cited by 3
Maruko, A., Ito, N., Oshima, K., Nishi, A., Kobayashi, Y., & Okada, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1600176 · Cited by 4
“Mutations in TREM2 increase the risk of late-onset AD and frontotemporal dementia (Borroni et al., 2014), and microglia de fi cient in TREM2 have a shortened migration distance to nerve damage and a reduced ability to respond to nerve damage (Mazaheri et al., 2017).”
Majumder, D. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11550-2 · Cited by 1
Zhou, A., Zhang, W., Ren, C., Zhou, J., Chang, H., & Ren, X. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.908527 · Cited by 2
“The expression of TREM-2 is upregulated on activated microglia, modulating the biological function of phagocytosis (8, 9), survival (10), chemotaxis, and response to neuronal injury (11).”
BackgroundHu, W. W., Zeng, H., Lü, J., Li, T., Liu, X., Liu, Y., Wen, W., Shen, W., Chen, H., & Chen, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-09262-x · Cited by 3
“The loss of TREM2 function impairs microglial response to amyloid plaques, leading to a toxic cellular state 11 .”
Dual Role of Microglial TREM2 in Neuronal Degeneration and Regeneration after Axotomy
Pottorf, T. S., Lane, E. L., Haley-Johnson, Z., Ukmar, D. N., Amores-Sanchez, V., Correa-Torres, P. M., & Álvarez, F. J. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.0112-26.2026 · Cited by 2
Impaired Efferocytosis of Pericytes and Vascular Smooth Muscle Cells in Diabetic Retinopathy
Gardiner, T. A., Little, K., & Stitt, A. W. (2025) · Cells · doi:10.3390/cells14171349 · Cited by 2
“Therefore in the context of EF, TREM2 is obviously central to the promotion of multiple EF-related function, including chemotaxis [87], cell migration, and phagocytosis [71], but not as a specific PS receptor.”
Association of daily sleep duration with the incident dementia by serum soluble TREM2 in a community
Ohara, T., Hata, J., Tanaka, M., Honda, T., Yamakage, H., Inoue, T., Hirakawa, Y., Kusakabe, T., Shibata, M., Kitazono, T., et al. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17634 · Cited by 2
Blank-Stein, N., Mayer, M., & Mass, E. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.08.001 · Cited by 4
Loss of TREM2 reduces hyperactivation of progranulin deficient microglia but not lysosomal pathologyPreprint
Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J. S., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind-Mark, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.08.451574 · Cited by 2
“This is the opposite phenotype of Trem2 knockout (KO) microglia, which are locked in a homeostatic state (Gotzl et al., 2019; Keren-Shaul et al., 2017; Kleinberger et al., 2017; Krasemann et al., 2017; Mazaheri et al., 2017; Nugent et al., 2020).”
InfluentialSelf-citationFruhwürth, S., Reinert, L. S., Öberg, C., Sakr, M., Henricsson, M., Zetterberg, H., & Paludan, S. R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.16.532882 · Cited by 2
Pesämaa, I., Müller, S. A., Robinson, S., Darcher, A., Paquet, D., Zetterberg, H., Lichtenthaler, S. F., & Haass, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.15.545187 · Cited by 2
Self-citationNegro‐Demontel, M. L., Evans, F., Cawen, F. A., Fitzpatrick, Z., Mason, H. D., Alí‐Ruiz, D., & Peluffo, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.06.611174 · Cited by 2
“The impaired extension of microglial processes towards a laser injury, with no affectation of the basal process motility, was also observed in TREM2 knockout mice 43 , again suggesting functional convergence between these two receptors.”
Myers, S. J., Medapati, M. R., Allman, B. L., Pasternak, S., Whitehead, S. N., & Roseborough, A. D. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101261 · Cited by 1
“…surface receptor that functions via its interaction with the DAP12 protein to initiate pathways that promote phagocytosis, survival, chemotaxis, inflammatory responses, and proliferation (Keren-Shaul et al., 2017; Wang et al., 2020; Hsieh et al., 2009; Zheng et al., 2017; Mazaheri et al., 2017).”
Hemati, H., Blanton, M. B., True, H., Koura, J., Khadka, R., Grant, K. A., & Messaoudi, I. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.07.022 · Cited by 3
Zhu, S., Yang, T., Sheng, L., & Shi, L. (2026) · Frontiers in Ophthalmology · doi:10.3389/fopht.2026.1804578 · Cited by 1
“This indicates that TREM2 is required to initiate an effective, protective DAM response characterized by enhanced phagocytic capacity and suppression of excessive in fl ammation (44).”
Hirota, Y., Yamamoto, J., Takatori, S., Sakakibara, Y., Takei, K., 佐治多美子, Sekiya, M., Tomita, T., & Iijima, K. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00032-1 · Cited by 1
Yang, Y. P., Su, X., Zhuang, Z., Hu, P., Wang, M., Liao, Z., Yang, P., & Hu, J. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.5.67 · Cited by 1
“15 Furthermore, TREM2 has been implicated in modulating inflammatory response intensity.”
Microglial ITAM & ITIM Signaling in Neurodegenerative Disease and Brain Aging
Mangalmurti, A., Bonheur, A., & Lukens, J. R. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169910 · Cited by 2
Liang, J., Menon, A., Tomco, T., Bhattarai, N., Smith, I. N., Khrestian, M., Formica, S. V., Eng, C., Buck, M., & Bekris, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179667 · Cited by 1
Hat die Alzheimer-Forschung versagt?: Das Scheitern amyloidbasierter klinischer Studien
Haass, C., & Levin, J. (2019) · Der Nervenarzt · Cited by 1
Self-citationKotredes, K. P., Oblak, A. L., Pandey, R. S., Lin, P. B., Garceau, D. T., Williams, H. M., Uyar, A., O’Rourke, R., O’Rourke, S., Ingraham, C. M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-580913/v1 · Cited by 1
“Single nucleotide polymorphisms (SNP) found in TREM2 have been shown to regulate 15 microglial function (36, 42, 43), the most widely studied being the R47H missense mutation in exon 2.”
BackgroundKlimmt, J., Gonçalves, C. C., Montgomery, J. V., Müller, S. A., Bublitz, M., Filser, S., Paeger, L., Nuscher, B., Dannert, A., Roeber, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.699077 · Cited by 1
Self-citationHuman IL-34 Deficiency Primes Microglia Toward Alzheimer’s Disease-Associated StatesPreprint
Hernández-Rasco, F., Ruiz, R. R., de Rojas, I., Puerta, R., Garcia-Mayor, C., Espinosa‐Oliva, A. M., García‐Revilla, J., Bayón-Buján, P., Rivera-Ramos, A., Oualit, F. R., et al. (2026) · medRxiv · doi:10.64898/2026.02.21.26346696 · Cited by 3
Boza‐Serrano, A., Ruiz, R., Sanchez-Varo, R. M., Yang, Y., García‐Revilla, J., Jiménez-Ferrer, I., Paulus, A., Wennström, M., Vilalta, A., Allendorf, D. H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/477927
What the government does at night
Martin, J. (1993) · The New York times book review
He, M. (2021) · eScholarship (California Digital Library)
Jadhav, V. (2021) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2086
Myelin pruning by microglia during development
Weikert, U. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7415
Metadata
- Authors
- Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Trümbach, D., Wurst, W., Brunner, B., Bultmann, S., Tahirovic, S., Kerschensteiner, M., Misgeld, T., Butovsky, O., & Haass, C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- LMU Klinikum (DE)
- Munich Cluster for Systems Neurology (DE)
- Brigham and Women's Hospital (US)
- Ludwig-Maximilians-Universität München (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Helmholtz Munich (DE)
- Center for Integrated Protein Science Munich (DE)
- Corresponding author
- Haass, Christian
- ORCID
- Venue
- The EMBO Reports
- Published
- 2017-05-08
- Volume
- 18
- Issue
- 7
- Pages
- 1186-1198
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC5494532
- OpenAlex
- W2612288104
- Cited by
- 351
- References
- 69
- Citations by year
- 2026: 37 · 2025: 34 · 2024: 39 · 2023: 35 · 2022: 40 · 2021: 41 · 2020: 44 · 2019: 34 · 2018: 36 · 2017: 10
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (EXC 1010, Mi 694/4‐1(SPP1710)/7‐1/8‐1)
- European Union's Seventh Framework Program (FP7/2007–2013)
- ERC (321366, 616791)
- Cure Alzheimer's
- Center for Integrated Protein Science Munich (EXC 114)
- Hans‐and‐Ilse‐Breuer Foundation
- German Science Foundation Collaborative Research Centre (870)
- Helmholtz Portfolio Theme “Supercomputing and Modeling for the Human Brain”
- NIH‐NINDS (1R01NS088137)
- NIA (1R01AG051812)
- National Multiple Sclerosis Society (5092A1)
- Amyotrophic Lateral Sclerosis Association (ALSA2087)
- Nancy Davis Foundation
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, microglia, chemotaxis, microglial migration, neuronal injury, loss of function, microglial transcriptome, Alzheimer's disease, frontotemporal lobar degeneration, somatosensory cortex, neurodegeneration
- MeSH terms
- Loss of Function Mutation, Alzheimer Disease, Cells, Cultured, Chemotaxis, Humans, Membrane Glycoproteins, Neurons, Phagocytosis, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Gene Expression Profiling, Myeloid Cells, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.